WE CHOSE TO LOCATE IN FLEMINGSBERG2021-12-01T08:58:49+01:00

Why we want to grow in Flemingsberg

Get to know some of the successful companies that have chosen to locate in Flemingsberg. Campus Flemingsberg is a multi-disciplinary academic environment offering world-class research. Here we have the right conditions, together with Uppsala-Stockholm, to be one of northern Europe’s most important life sciences hubs. Campus Flemingsberg is also an attractive place for knowledge-intensive companies that want to locate close to higher education institutions and a university hospital. Meet some of the companies that have enjoyed success in Flemingsberg below.

Cellaviva: improving lives through stem cell technology

“Cellaviva was founded by researchers from Karolinska Institutet, in the belief that stem cells will revolutionize how complex and incurable diseases are treated. We are a biobank that helps expectant parents to save stem cells from the umbilical cord at birth, in a so-called family bank. The aim is to make high-quality, potent cells available quickly, if medical needs arise. This creates treatment opportunities and expands therapy options for the whole family,”

Biomedrex Genetics is developing antiviral drugs

“We’re developing a completely new drug to combat viral infections – an antiviral drug – using modern genetic engineering. Our methods are based on the Nobel-winning CRISPR technology that paves the way to new, targeted treatments,” says Theodor Pramer, CEO of Biomedrex Genetics.

XNK Therapeutics lays the groundwork for GMP facility in Flemingsberg

"Flemingsberg is the place in the world you want to be if you work with NK cells. There is a strong research facility here with a world-leading research group and proximity to a clinic that really knows NK cells. We recently started the construction of a new GMP facility with an associated research laboratory of 350 square meters for our NK cell therapy. The new facility is being built at Novum in Flemingsberg and, once the facility is completed in 2022, it will give us complete control over the entire development chain."

AlzeCure Pharma

“Our research and development has been conducted in co-operation with Karolinska Institutet and Karolinska University Hospital here in Flemingsberg, and the stimulating environment with access to leading research in the area, and the positive climate on Campus Flemingsberg encourages exciting co-operation,”

Bactiguard

“Previously, we had offices in central Stockholm. When we needed more space to establish an integrated facility for all our activities, including production, Flemingsberg was the natural choice. The main reason for this was proximity to Karolinska University Hospital, Karolinska Institutet, Swedish Red Cross University College, and other key partners for us. Our technology also has links with the 1912 Nobel Prize, (read more on our website), so what could be more appropriate for our new address than Alfred Nobel Allé,”

Inhalation Sciences Sweden

“In Flemingsberg, we have access to the advanced labs that we need, and it offers the right facilities we need to expand,” says Manoush Masarrat, CEO of Inhalation Sciences.

Mando Group

“We conducted our research and development in collaboration with KI and Karolinska University Hospital here in Flemingsberg – work that paved the way for our insights into what causes obesity and ultimately its treatment. The positive environment at Campus Flemingsberg encourages original thinking and collaboration and has created a stimulating environment that has been decisive for us,” says Cecilia Bergh.

NextCell Pharma

“Flemingsberg is exactly the right place for us thanks to its proximity to collaboration partners and the clinical research conducted at Karolinska University Hospital. Furthermore, it’s the right place for us to grow given how Flemingsberg as a whole is flourishing and developing,” says Mathias Svahn.

Sprint Bioscience

In Flemingsberg, there is an opportunity for us to grow and offer a good working environment for our employees. Here are the benefits of proximity to research at Karolinska Institutet and clinical research at Karolinska University Hospital. We are also attracted by the fact that the area represents innovation and looks forward with excitement to the upcoming development and that we, together with the other Life Science companies in the area, will be an important part of the new Flemingsberg.

Want to know more?
Subscribe to our newsletter.

SUBSCRIBE
CF_logo_neg

Want to know more?
Subscribe to our newsletter.

SUBSCRIBE
Go to Top